Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1216170.RAZcSE6LGnWv2wtvIiJpjYAsm6Xri3hBwJci9nSPYbRXI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1216170.RAZcSE6LGnWv2wtvIiJpjYAsm6Xri3hBwJci9nSPYbRXI130_assertion type Assertion NP1216170.RAZcSE6LGnWv2wtvIiJpjYAsm6Xri3hBwJci9nSPYbRXI130_head.
- NP1216170.RAZcSE6LGnWv2wtvIiJpjYAsm6Xri3hBwJci9nSPYbRXI130_assertion description "[This approach, which has been exemplified by the development of small-molecule BRAF inhibitors and the BRAF/MEK inhibitor combination for BRAF-mutant melanoma, has brought new hope to patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216170.RAZcSE6LGnWv2wtvIiJpjYAsm6Xri3hBwJci9nSPYbRXI130_provenance.
- NP1216170.RAZcSE6LGnWv2wtvIiJpjYAsm6Xri3hBwJci9nSPYbRXI130_assertion evidence source_evidence_literature NP1216170.RAZcSE6LGnWv2wtvIiJpjYAsm6Xri3hBwJci9nSPYbRXI130_provenance.
- NP1216170.RAZcSE6LGnWv2wtvIiJpjYAsm6Xri3hBwJci9nSPYbRXI130_assertion SIO_000772 25180764 NP1216170.RAZcSE6LGnWv2wtvIiJpjYAsm6Xri3hBwJci9nSPYbRXI130_provenance.
- NP1216170.RAZcSE6LGnWv2wtvIiJpjYAsm6Xri3hBwJci9nSPYbRXI130_assertion wasDerivedFrom befree-2016 NP1216170.RAZcSE6LGnWv2wtvIiJpjYAsm6Xri3hBwJci9nSPYbRXI130_provenance.
- NP1216170.RAZcSE6LGnWv2wtvIiJpjYAsm6Xri3hBwJci9nSPYbRXI130_assertion wasGeneratedBy ECO_0000203 NP1216170.RAZcSE6LGnWv2wtvIiJpjYAsm6Xri3hBwJci9nSPYbRXI130_provenance.